Table 1.
Spectra of APC mutations in carcinomas from HNPCC patients
| Tumor ID | APC nt change | Codon | Target sequence |
| Point mutations | |||
| T27 | C > T | 332 | CpG |
| T533 | C > T | 1 338 | CpG |
| K1, C × 7* | C > T | 1 450 | CpG |
| Frameshift mutations | |||
| C × 7* | 1 bp ins | 847 | TCTCaAAAAAGAT |
| C086* | 1 bp ins | 941 | TCGGaAAAATTCA |
| K40 | 1 bp ins | 1 454 | CCTaAAAAATAAA |
| 22 | 1 bp ins | 1 554 | GCAGaAAAAAACTAT |
| C x 10 | 1 bp ins | 1 935 | TTTCCCCaAGTCA |
| K10 | 1 bp del | 907 | TCTgGGTCT |
| C086* | 1 bp del | 1 464 | AAGAGAGagAGTGG |
| K39 | 1 bp del | 799 | GATtaTGTT |
| T10 | 1 bp del | 1 416 | AGTGGcATTATA |
Note: ID means tumor identification; nt stands for neocleotide; ‘>’ for transition or transvertion; each tumor with more than 2 mutations marked by *; del for deletion; ins for insertion; small letter for nucleotide frameshift.